GRAFTON™ DBF INJECT Highly Osteoinductive Demineralized Bone Matrix (DBM) Fiber for Minimally Invasive and Open Procedures

Grafton™ DBF inject is the first pre-loaded targeted bone graft delivery system that combines a highly osteoinductive1 DBM with a unique fiber technology and graft delivery syringe that can be injected into the surgical site.

DOWNLOAD THE BROCHURE
Image of Grafton DBF Inject

Overview

All-in-One Bone Graft Delivery Device

This all-in-one method features our patented* fiber flow technology and shows you how to efficiently hydrate and deliver our highly osteoinductive, 100% carrier-free DBM into your surgical site.

Integration with Catalyft™ Expandable Lumbar Cage

Grafton™ DBF Inject seamlessly integrates with Catalyft™ with bone graft flowing through the inserter and expanded into implant to completely fill the disc space.

Learn more about Catalyft™

Grafton™ DBF Inject with Catalyft™ expandable cage

Precisely Controlled Delivery

Grafton™ DBF Inject is a precisely controlled bone graft delivery system that enables pre- and post-packing of graft material in the interbody space through integrated cannulas. 

It can be used with certain Medtronic interbody devices, when hydrated with bone marrow aspirate (BMA) for spinal and orthopedic procedures.

potential applications

  • TLIF
  • PLIF/MidLIF
  • ACDF
  • ALIF
  • LLIF
  • SI Fusion
  • Corpectomies
  • Spinal defects
  • Pelvic
  • Extremities
  • Foot and ankle
Closeup of bone graft during foot and ankle procedure

Foot and Ankle

Closeup of bone graft during extremities procedure.

Extremities

Closeup of bone graft during spinal defect procedure.

Spinal Defect

Closeup of bone graft during pelvis procedure.

Pelvis

Closeup of Grafton DBF inject used during a corpectomy.

Corpectomy

Closeup of Grafton DBF inject used during TLIF.

TLIF

product features

Unique Syringe Design

Unique syringe design allows for precise delivery of our premium, highly osteoinductive DBM fiber, into traditionally difficult to access sites.

Fiber Flow Technology

Grafton™ DBF Inject and its patented* fiber technology enables the first flowable carrier free Fiber DBM on the market today.

improved workflow

By eliminating the need for a bone funnel and tamp, Grafton™ DBF inject has the potential to reduce the number of steps needed to deliver bone graft and improve OR efficiencies.

All-in-One Hydration

Our unique syringe design allows for seamless hydration and delivery of our premium, Grafton™ DBF bone graft. 

100% Carrier-Free DBM Fiber

By eliminating the glycerol carrier, Grafton™ DBF Inject improves on the groundbreaking Grafton™ DBM technology by producing a more versatile osteoinductive bone graft.1

Closeup of the Grafton DBF inject pre-loaded syringe.

CLINICAL EVIDENCE 

Bone Formation Clinical Evidence

Grafton™ family of DBM's were the first fiber-based DBM's on the market. Our aseptically processed fibers have some of the highest osteoinductive scores1 of all the products we have tested† and this interconnected mesh of fibers enhances the osteoconductive potential of the  product by providing a path for cellular infiltration.2

pdf Preclinical Evidence on Bone Formation  (.pdf)

Download to view a summary of preclinical evidence for bone formation with Grafton™ DBF Inject.

4.3MB

DOWNLOAD WHITEPAPER
Download the PDF.

PRODUCT RESOURCES

Product Specifications

Part Number 

Description

Graft Volume

T50303INT

Grafton™ DBF Inject

3cc

T50306INT

Grafton™ DBF Inject

6cc

T50309INT

Grafton™ DBF Inject

9cc

Integration with catalyft™ expandable cage

The integrated design of Catalyft™ PL Expandable Interbody System and Grafton™ DBF Inject streamlines the workflow and precisely delivers bone graft.

Grafton™ DBF Inject* boosts seamless fusion by flowing through the inserter and expanded implant to completely fill the disc space.

*Grafton DBF Inject can be used with the Catalyft™ PL Expandable Interbody System when hydrated with bone marrow aspirate (BMA) for spinal and orthopedic procedures.

Step 2a Inject DBF

Interested in Grafton™ Inject and/or Catalyft™?

Complete our contact form and your local sales representative will contact you.

Contact us
banner image

Referenced path does not exist

*Third party brands are trademarks of their respective owners.

*

Patent number: US 10,660,685 B2.

†

Animal testing is not necessarily indicative of human clinical outcomes.

1

Data on file. Memo RAT OI Chart 09-01-2022 version 1. Based on internal testing in an athymic rat model. Histology scoring based on Edwards JT, Diegmann MH, Scarborough NL. Osteoinduction of human demineralized bone: characterization in a rat model. Clin Orthop Relat Res. 1998;357:219-228.

2

Martin, G.J. et al. Spine. 1999;24(7):637-645.

See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at www.medtronic.eu